AAO-HNSF Clinical Practice Guideline: Tinnitus
Record details
- Authors: Tunkel DE, Bauer CA, Sun GH, et al.
- Journal / source: Otolaryngology–Head and Neck Surgery (2014)
- Design: Clinical practice guideline (US)
- Sample: Guideline (23-author multidisciplinary panel)
- Primary endpoint: —
- Randomized: No · Sham/placebo-controlled: No · Independent of the manufacturer: Yes
What this research found
RECOMMENDS: hearing-aid evaluation (with hearing loss) and CBT for persistent bothersome tinnitus. OPTION: sound therapy ('may recommend'). AGAINST routine use: medical therapy (antidepressants, anticonvulsants, anxiolytics, intratympanic drugs), dietary supplements (Ginkgo, melatonin, zinc), and rTMS. NO RECOMMENDATION: acupuncture.
Guidelines are consensus documents, not new trial data. Where the three major guidelines disagree — chiefly on sound therapy (AAO-HNSF: option; NICE and the European guideline: research-only; the German S3 guideline: against sound generators) — this platform shows the disagreement rather than picking a side. Statement strengths read from the published abstracts; full-text verbatim wording not independently re-read.
Limitations and conflicts of interest
US-focused; 2014 evidence base.
Funding / conflicts: Professional society guideline.
Primary sources
Used as evidence for
This is an original summary from the Tinnitus Evidence verified database, checked against the primary source — not a reproduction of the publisher's abstract.